Terkko Navigator / -/ Feeds / " ( ( Syöpärokotteet )|( Syöpärokotus )|( Syöpärokote )|( ( ( Kasvaimet )|( Tuumorit"

MHC-II molecules present RhoC-derived peptides on the surface of tumour cells

Cancers, Vol. 14, Pages 2438: Lymph Nodes as Anti-Tumor Immunotherapeutic Tools: Intranodal-Tumor-Specific Antigen-Pulsed Dendritic Cell Vaccine Immunotherapy

Polymeric Nanoparticle-Based Vaccine Adjuvants and Delivery Vehicles.

Protein and Peptide Nanocluster Vaccines.

The paradigm shift in treatment from Covid-19 to oncology with mRNA vaccines

Genetic variability in minor capsid protein (L2 gene) of human papillomavirus type 16 among Indian women

Human papillomavirus vaccine efficacy against invasive, HPV-positive cancers: population-based follow-up of a cluster-randomised trial

Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine

A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines

Oncolytic Adenovirus Type 3 Coding for CD40L Facilitates Dendritic Cell Therapy of Prostate Cancer in Humanized Mice and Patient Samples

Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trials

Eradication of human papillomavirus and elimination of HPV-related diseases - scientific basis for global public health policies

Gender-neutral vaccination provides improved control of human papillomavirus types 18/31/33/35 through herd immunity: Results of a community randomized trial (III)

Evaluation of HPV type-replacement in unvaccinated and vaccinated adolescent females-Post-hoc analysis of a community-randomized clinical trial (II)

CMR findings after COVID-19 and after COVID-19-vaccination—same but different?

Vaccines, Vol. 10, Pages 731: Immunological Aspects of Human Papilloma Virus-Related Cancers Always Says, “I Am like a Box of Complexity, You Never Know What You Are Gonna Get”

Vaccines, Vol. 10, Pages 740: Vaccine Therapy in Non-Small Cell Lung Cancer

Cancer immunotherapy using artificial adjuvant vector cells to deliver NY-ESO-1 antigen to dendritic cells in situ

Vaccines, Vol. 10, Pages 734: COVID-19 Vaccination in Health Care Workers in Italy: A Literature Review and a Report from a Comprehensive Cancer Center

Current Oncology, Vol. 29, Pages 3364-3374: Antibody Response to COVID-19 mRNA Vaccines in Oncologic and Hematologic Patients Undergoing Chemotherapy

IJMS, Vol. 23, Pages 2594: Identification of Neoantigens in Cancer Cells as Targets for Immunotherapy

Photosensitizer-induced HPV16 E7 nanovaccines for cervical cancer immunotherapy

Identifying novel tumor-related antigens and immune phenotypes for developing mRNA vaccines in lung adenocarcinoma

IJMS, Vol. 23, Pages 5167: Cancer Stem Cells and Their Possible Implications in Cervical Cancer: A Short Review

IJERPH, Vol. 19, Pages 5694: Awareness and Knowledge of HPV, HPV Vaccination, and Cervical Cancer among an Indigenous Caribbean Community

IJERPH, Vol. 19, Pages 5694: Awareness and Knowledge of HPV, HPV Vaccination, and Cervical Cancer among an Indigenous Caribbean Community

Emerging role of natural products in cancer immunotherapy

Targeting Mutant Kirsten Rat Sarcoma Viral Oncogene Homolog in Non-Small Cell Lung Cancer: Current Difficulties, Integrative Treatments and Future Perspectives

COVID-19 vaccines elicit strong cellular immunity and robust clinical protection in CLL

HPV vaccines beat cervical cancer

Prevalence and Distribution of Vaccine-Preventable Genital Human Papillomavirus(HPV) Genotypes in Ghanaian Women Presenting for Screening

Thermotropic effects of PEGylated lipids on the stability of HPPH-encapsulated lipid nanoparticles (LNP)

Cancers, Vol. 13, Pages 2735: Magnetic Nanostructures as Emerging Therapeutic Tools to Boost Anti-Tumour Immunity

Vaccines, Vol. 10, Pages 78: Circulating Cytokines in Metastatic Breast Cancer Patients Select Different Prognostic Groups and Patients Who Might Benefit from Treatment beyond Progression

Cancers, Vol. 12, Pages 2831: Treatment Combinations with DNA Vaccines for the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Cancers, Vol. 12, Pages 3581: Strategies for Cancer Immunotherapy Using Induced Pluripotency Stem Cells-Based Vaccines

Vaccines, Vol. 9, Pages 439: Bacillus Calmette–Guérin Immunotherapy for Cancer

Cancers, Vol. 13, Pages 5819: Vaccines as Priming Tools for T Cell Therapy for Epithelial Cancers

Cancers, Vol. 12, Pages 2908: Exploring Essential Issues for Improving Therapeutic Cancer Vaccine Trial Design

Cancers, Vol. 12, Pages 2908: Exploring Essential Issues for Improving Therapeutic Cancer Vaccine Trial Design

Cancers, Vol. 12, Pages 3101: Plant-Derived Natural Compounds in Genetic Vaccination and Therapy for HPV-Associated Cancers

Cancers, Vol. 12, Pages 3397: Cold-Inducible RNA Binding Protein as a Vaccination Platform to Enhance Immunotherapeutic Responses Against Hepatocellular Carcinoma

Cancers, Vol. 12, Pages 3397: Cold-Inducible RNA Binding Protein as a Vaccination Platform to Enhance Immunotherapeutic Responses Against Hepatocellular Carcinoma

Cancers, Vol. 13, Pages 266: Immunotherapeutic Efficacy of Retargeted oHSVs Designed for Propagation in an Ad Hoc Cell Line

Cancers, Vol. 13, Pages 2237: Intratumoral (Poly-ICLC) Therapy for Dogs with Advanced Cancers: First Report on Clinical Effectiveness, Quality of Life, and Adverse Events

Cancers, Vol. 13, Pages 3667: DC-Derived Exosomes for Cancer Immunotherapy

Vaccines, Vol. 10, Pages 164: COVID-19 Vaccination in Cancer Patients Older than 70 Years Undergoing Active Treatment. Seroconversion Rate and Safety

Vaccines, Vol. 10, Pages 600: Gastric Cancer and Viruses: A Fine Line between Friend or Foe